C

Celadon Pharmaceuticals PLC
LSE:CEL

Watchlist Manager
Celadon Pharmaceuticals PLC
LSE:CEL
Watchlist
Price: 13.4 GBX Market Closed
Market Cap: 9.2m GBX

Net Margin
Celadon Pharmaceuticals PLC

-1 019.7%
Current
-27 679%
Average
3.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 019.7%
=
Net Income
-381.9m
/
Revenue
37.4m

Net Margin Across Competitors

No Stocks Found

Celadon Pharmaceuticals PLC
Glance View

Market Cap
9.2m GBX
Industry
N/A

Summerway Capital Plc engages in acquiring companies or businesses that has the potential for strategic, operational, and performance improvement. The firm is engaged in research, cultivation, manufacturing and supply of cannabinoid-based medicines. The firm is focused on growing indoor hydroponic cannabis initially for the chronic pain market. The company is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions such as autism. The firm's facility comprises an indoor, closed-loop hydroponic system to ensure cannabis plants are cultivated under a highly specific climate, light and with irrigation control. The firm's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.

CEL Intrinsic Value
Not Available
C
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-1 019.7%
=
Net Income
-381.9m
/
Revenue
37.4m
What is the Net Margin of Celadon Pharmaceuticals PLC?

Based on Celadon Pharmaceuticals PLC's most recent financial statements, the company has Net Margin of -1 019.7%.

Back to Top